tenk.fyi

Immunovant, Inc.

IMVTNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

-

Net Income

-$413.8M

59.6% YoY

EPS

$-2.73

45.2% YoY

Cash

$714.0M

12.4% YoY

FY 2025 · As of 2025-03-31